Stem cells and cardiac regeneration;Celulas troncales (stem cells) y regeneracion cardiaca

Medicina

Volumn 66, Issue 6, 2006, Pages 574-582

  Millan, Maria Ines Perez ^a   Lorenti, Alicia ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Cardiac regeneration; Stem cells

Indexed keywords

CELL MARKER; CYTOKINE;

ARTICLE; CARDIOMYOPLASTY; CELL CULTURE; CELL DAMAGE; CELL FUNCTION; CELL FUSION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL TYPE; EMBRYONIC STEM CELL; HEART DISEASE; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; MEDICAL RESEARCH; REGENERATIVE MEDICINE; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE SPECIFICITY;

ADULT; ADULT STEM CELLS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GUIDED TISSUE REGENERATION; HEART; HUMANS; MYOCYTES, CARDIAC; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 33846436433     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. McCulloch EA, Till JE. Perspectives on the properties of stem cells. Nature Medicine 2005; 11: 1026-8.
2. Loeffler M, Potten CS. Stem cells and cellular pedigree - a conceptual introduction. In: Stem Cells. CS Potten (eds). London: Academic press 1997, p1-27.
3. Maltsev VA, Rohwedel J, Hescheler J, Wobus AM. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 1993; 44: 41-50.
4. Stem cells: Scientific Progress and future research directions. Department of health and human services. 2001; pp ES1-ES10. En: http://www.nih.gov/news/stemcell/scirepor.htm.
5. Prosper F, Verfaillie C. Células madre adultas. An Sist Sanit Navar 2003; 26: 345-56.
6. Zipori D. The stem state: plasticity is essential, whereas self-renewal and hierarchy are optional. Stem Cells 2005; 23: 719-26.
7. Bach SP, Renehan AG, Potten CS. Stem cells: the intestinal stem cells as a paradigm. Carcinogenesis 2000; 21: 469-76.
8. Blanpain C, Lowry W, Geoghegan A, Polak L, Fuchs E. Self-renewal, multupotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004; 118: 635-48.
9. Webb A, Li A, Kaur P. Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation 2004; 72: 387-95.
10. Faris RA, Konkin T, Halpert G. Liver stem cells: a potential source of hepatocytes for the treatment of human liver disease. Artificial Organs 2001: 25: 513-21.
11. Lorenti A. Células progenitoras hepáticas. Medicina (Buenos Aires) 2001; 61: 614-20.
12. Bouwens L, Rooman I. Regulation of pancreatic beta-cell mass. Physiol Rev. 2005; 85: 1255-70.
13. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; 100: 157-68.
14. Haller H, de Groot K, Bahlmann F, Elger M, Fliser D. Stem cells and progenitor cells in renal disease. Kidney International 2005; 68: 1932-6.
15. Kitamura S, Yamasaki Y, Makino H. Establishment of renal stem/ progenitor-like cell line from S3 segment of proximal tubules in adult rat kidney. Kidney International 2005; 68: 1966.
16. Rosenzweig A. Circulating endothelial progenitors-cells as biomarkers. NEJM 2005; 353: 1055-7.
17. Gage FH, Ray J, Fisher LJ. Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 1995; 18: 159-92.
18. Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science 2000; 288: 1660-3.
19. Zammit P, Beauchamp J. The skeletal muscle satellite cell: stem cell or son of stem cell. Differentiation 2001; 68: 193-204.
20. Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. PNAS 2005; 102: 8692-7.
21. Michalopoulos GK, De Frances MC. Liver regeneration. Science 1997; 276: 60-6.
22. Fausto. Liver regeneration. Journal of Hepatology 2000; 32 (Suppl 1): 19-31.
23. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961;9: 493-7.
24. Alameddine HS, Louboutin JP, Dehaupas M, Sebille A, Fardeau M. Functional recovery induced by satellite cell grafts in irreversibly injured muscles. Cell Transplantation 1994; 3: 3-14.
25. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998; 83: 1-14.
26. Anversa P, Rota M, Urbanek K, et al. Myocardial aging. A stem cell problem. Basic Res Cardiol. 2005; 100: 482-93.
27. Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev. 2005; 85: 1373-416.
28. Morgan JP. Cellular physiology of myocyte contraction. In: Heart Failure. Poole-Wilson P, Colucci W, Masse B, Chaterjee K, Coats A (eds). Churchill Livingston Inc. 1997, p 1-11.
29. o Edición, 1995, pp: 573-89.
30. Beltrami A, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. NEJM 2001; 344: 1750-7.
31. Mathur A, Martin JF. Stem cells and repair of the heart. The Lancet 2004; 364: 183-92.
32. Ross J. Cell-extracellular matrix interactions. En: Frontiers in Tissue Engineering. CW Patrick, A Mikos, L McIntire (eds). Elsevier Science Ltd. UK 1998, p 15-27.
33. Bock-Marquette I, Saxena A, White M, DiMalo J, Srivastava D. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004; 432: 466-72.
34. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplantation 1997; 6: 125-34.
35. Strom S, Chowdhury JR, Fox IY. Hepatocyte transplantation for the treatment of human disease. Seminars in Liver Disease 1999; 19: 39-48.
36. Nadal-Ginard B. Inducción de nuevos cardiomiocitos en el corazón adulto: futuro de la regeneración miocárdica como alternativa al trasplante. Rev Esp Cardiol 2001; 54: 543-50.
37. Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: crypreservation. Artificial Organs 2004; 28: 182-8.
38. Kim WS, Vacanti JP, Cima L, et al. Cartilage engineered in predetermined shapes employing cell transplantation on synthetic biodegradable polymers. Plast Reconstr Surg 1994; 94: 233-40.
39. Pouly J, Hagege AA, Vilquin JT, et al. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?. Circulation 2004; 110: 1626-31.
40. Menasché P, Desnos M. Cardiac reparation: fixing the heart with cells, new vessels and genes. Eur Heart J 2002; 4: 73-4.
41. Dimmeler S, Zeiher AM. Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol. 2004; 44: 464-6.
42. Atkins B, Hueman M, Meuchel J, Cottman M, Hutcheson K, Taylor D. Myogenic cell transplantation improves in vivo regional performance in infarctes rabbit myocardium. J Heart Lung Transplant. 1999; 18: 1173-80.
43. Menasché P, Hagège A, Scorsin M, et al. Myoblast transplantation for heart failure. The Lancet 2001; 357: 279-80.
44. Hassink RJ, Brutel de la Rivière A, Mummery CL, Doevendans P. Transplantation of cells for cardiac repair. J Am Coll Cardiol 2003; 41: 711-8.
45. Chachques J, Acar C, Herreros J, et al. Cellular Cardiomyoplasty: Clinical Application. Ann Thorac Surg 2004; 77: 1121-30.
46. Caviedes R, Liberona J, Hidalgo J, Tascon S, Salas K, Jaimovich E. A human skeletal cell line obtained from an adult donor. Biochimica et Biophysica Acta 1992; 1134: 247-55.
47. Camargo FD, Chambers SM, Goodell MA. Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif 2004; 37: 55-65.
48. Sell S. Stem cell origin of cancer and differentiation therapy. Critical Reviews in Oncology/hematology 2004; 51: 1-28.
49. Bjornson C, Rietze R, Reynolds B, Magli C, Vescovi A. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283: 534-7.
50. Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells. Nature 2001; 414: 92-7.
51. Jiang Y, Jahagirdar B, Reinhardts L, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
52. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified Hematopoietic Stem Cells Can Differentiate Into Hepatocytes In Vivo. Nature Medicine 2000; 6: 1229-34.
53. Zuk P, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell 2002; 13: 4279-95.
54. Orlic D, Hill J, Arai A. Stem cells for myocardial regeneration. Circ Res 2002; 91: 1092-102.
55. Orlic D. The strength of plasticity: stem cells for cardiac repair. Int J Cardiol 2004; 95 Suppl 1: S16-9.
56. Zhang Y, Bai XF, Huang CX. Hepatic stem cells: existence and origin. World J Gastroenterol 2003; 9: 201-4.
57. Bianco P, Riminucci M, Gronthos S, Gehron Robey P. Bone marrow stromal cells: nature, biology, and potential applications. Stem Cells 2001; 19: 180-92.
58. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artificial Organs 2001; 25: 187-93.
59. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. PNAS 2001; 98: 10344-49.
60. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
61. Zuk P, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering 2001; 7: 211-28.
62. Tomita S. Cell-based therapy to regenerate myocardium: from bench to bedside. Artificial Organs 2004; 28: 40-4.
63. Lu L, Zhang J, Ramires F, Sun Y. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochemical and Biophysical Research Communication 2004; 320: 907-13.
64. Rezai N, Podor T, McManus B. Bone marrow cells in the repair and modulation of heart and blood vessels: emerging opportunities in native and engineered tissue and biomechanical materials. Artificial Organs 2004; 28: 142-51.
65. Rosenthal N. Prometheus's vulture and the stem-cell promise. NEJM 2003; 349: 267-74.
66. Perin E, Geng Y, Willerson J. Adult stem cell therapy in perspective. Circulation 2003; 107: 935-8.
67. Beltrami A, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-76.
68. Jackson K, Majka S, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107: 1395-402.
69. Yoon YS, Wecker A, Heyd L, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005; 115: 326-38.
70. Hamano K, Nishida M, Hirata K, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 2001; 65: 845-7.
71. Assmus B, Schächinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-17.
72. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. The Lancet 2004; 364: 141-8.
73. Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SUR-VIVE, and PROACTIVE. Eur J Heart Fail 2006; 8: 105-10.
74. Menasche P. The potential of embryonic stem cells to treat heart disease. Curr Opin Mol Ther 2005; 7: 293-9.
75. Menard C, Hagege AA, Agbulut O, et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. The Lancet 2005; 366: 1005-12.
76. Balsam L, Wagers A, Christensen J, Kofidis T, Weissman I, Robbins R. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668-73.
77. Murry CE, Soonpaa M, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-8.
78. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542-5.
79. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 2002; 416: 545-8.
80. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422: 897-901.
81. Alvarez-Dolado M, Pardal R, Garcia-Verdugo J, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968-73.
82. Wurmser AE, Nakashima K, Summers RG, et al. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature 2004; 430: 350-6.
83. Lee M, Lill M, Makkar R. Stem Cell Transplantation in Myocardial Infarction. Rev Cardiovasc Med 2004; 5: 82-98.
84. Amrani DL, Port S. Cardiovascular disease: potential impact of stem cell therapy. Expert Rev Cardiovasc Ther 2003; 1: 453-61.
85. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. The Lancet 2003; 361: 45-6.
86. Agbulut O, Vandervelde S, Al Attar N, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 2004; 44: 458-63.
87. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004; 8: 498-508.
88. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands and cytokines. Circulation 2001; 104: 1046-52.
89. Tomita S, Li R, Weisel R, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100 (Suppl II): II 247-56.
90. Swynghedauw B. Is adult cardiac myocyte still able to proliferate?. Med Sci (Paris) 2004; 20: 710-4.
91. Kim E, Li R, Weisel R, et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 2001; 122: 963-71.
92. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes H. Nanotubular highways for intercellular organelle transport. Science 2004; 303: 1007-10.
93. Koyanagi M, Brandes R, Haendeler J, Zeiher A, Dimmeler S. Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes. Circ Res 2005; 96; 1039-41.
94. Dawn B, Stein AB, Urbanek K, et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. PNAS 2005; 8; 102: 3766-71.
95. Oh H, Bradfute S, Gallardo T, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. PNAS 2003; 100: 12313-18.
96. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95: 911-21.
97. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005; 433: 647-53.
98. Linke A, Müller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. PNAS 2005; 102: 8966-71.
99. Wollert K, Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005; 96: 151-63.